Testosterone topical Tostrelle - ProStrakan
Alternative Names: CP 601B; TostrelleLatest Information Update: 13 Nov 2021
At a glance
- Originator Cellegy Pharmaceuticals
- Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Testosterone agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Female testosterone deficiency
Most Recent Events
- 31 Dec 2006 No development reported - Phase-II for Female testosterone deficiency in United Kingdom (Topical)
- 31 Dec 2006 No development reported - Phase-II for Female testosterone deficiency in USA (Topical)
- 27 Sep 2006 ProStrakan has proposed to acquire the testosterone topical gel Tostrelle from Cellegy